Can the fallopian tubes be left in place during a partial (subtotal) hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fallopian Tubes in Partial Hysterectomy

Yes, the fallopian tubes are routinely left in place during a partial (subtotal) hysterectomy, as this procedure specifically removes only the uterine body while preserving the cervix, fallopian tubes, and ovaries.

Understanding Partial Hysterectomy Anatomy

A partial or subtotal hysterectomy by definition removes only the upper portion of the uterus while leaving the cervix intact. The fallopian tubes and ovaries are not part of the standard surgical field for this procedure and remain in situ unless there is a specific indication for their removal.

When Fallopian Tubes ARE Removed

The fallopian tubes would only be removed during a partial hysterectomy if:

  • There is concurrent pathology requiring salpingectomy (such as hydrosalpinx, tubal disease, or ectopic pregnancy history)
  • Cancer risk reduction is indicated, particularly in women with BRCA1/BRCA2 mutations or other high-risk genetic variants, where risk-reducing salpingo-oophorectomy (RRSO) is recommended 1, 2
  • The patient specifically requests opportunistic salpingectomy for ovarian cancer risk reduction, though this is increasingly common practice regardless of hysterectomy type

Important Clinical Context

For women at increased ovarian cancer risk, both fallopian tubes AND ovaries must be removed together, as oophorectomy alone is clinically inappropriate for cancer prevention 1. The majority of high-grade serous ovarian cancers actually originate from the fallopian tubes, making their removal essential in risk-reduction surgery 1.

In BRCA1/BRCA2 carriers, RRSO (removing both tubes and ovaries) significantly reduces ovarian cancer risk and mortality, though a 2-4% residual risk of primary peritoneal cancer remains 1. Risk-reducing salpingectomy alone (removing only tubes while keeping ovaries) is not currently recommended as standard of care, as it may not provide the breast cancer risk reduction benefit that oophorectomy offers 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.